Actos - Biotech, Pharma and Life Science Channel
Actos, produced by Takeda Pharmaceuticals North America, Inc netted $2.5m in sales in 2009, the 9th highest in the world.
Actos is a type of thiazolidinediones, acting to increase sensitivity to Insulin. This sensitivity is lost in Type II Diabetes, the disease which Actos is prescribed for. Diabetes (Type II) is becoming increasingly common in the developed world, and may explain the high sales value of this drug.
Source; Adapted from BioPortfolio.com and Actos.com
Add the Actos News Channel to your RSS reader;
Follow the Actos Twitter feed;
News Articles
Stryker Metal Hip Recall: Lieff Cabraser Provides Answers to Hip Replacement Patients
Wendy Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that the firm issued today a list of answers to frequently asked ques...
Kent Klaudt, an injury lawyer at the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that Lieff Cabraser released today a video on th...
KALAMAZOO, Mich., May 15, 2013 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data in the latest issue of the scientific journal PLOS ONE (http:...
6.5 Million Jury Verdict in First Actos Trial Vacated by Court
The Miller Firm, LLC regrettably announces that after obtaining a Plaintiff’s verdict in the world’s first Actos™ trial, the Court has vacated the jury’s decision. On Apri...
The Miller Firm helps cancer victim obtain $6.5 million verdict against diabetes drug maker
Diabetes drug Actos prescribed to 10 million people worldwide at the center of verdict against Japanese manufacturer for failure to warn about bladder cancer...
Judge Nullifies Verdict in Diabetes Drug Case
DEERFIELD, Ill., May 1, 2013 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-12-518...
Huge Plaintiffs' Victory Seen In First Actos® Trial
NEW YORK, April 29, 2013 /PRNewswire/ -- Commenting on a $6.5 million dollar verdict reached this past Friday in a Los Angeles courtroom against Takeda Pharmaceuticals for injuries arising from t...
Takeda Responds to Verdict in Diabetes Drug Case
DEERFIELD, Ill., April 26, 2013 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC...
Consumer Reports: So Many Drugstores, So Many Prices; New Report Finds Price Mayhem At The Pharmacy
Tips for getting the best prices when you shop at the pharmacy; plus, why it pays to shop like a country mouse YONKERS, N.Y., March 28, 2013 /PRNewswire-USNewswire/ -- Con...
Events
None
Companies
None
Clinical Trials
Treating Nonalcoholic Steatohepatitis With Pioglitazone
Nonalcoholic steatohepatitis (NASH) is a common liver disease that resembles alcoholic hepatitis but occurs in persons who drink little or no alcohol. The etiology of NASH is unclear, but...
This study will compare the safety, tolerability and efficacy of aleglitazar and Actos® in patients with type 2 diabetes and symptomatic NYHA class II heart failure. Eligible patients wil...
A Study of Aleglitazar in Patients With Type 2 Diabetes
This 6 arm study will assess the efficacy, safety, tolerability and pharmacokinetics of aleglitazar therapy in patients with Type 2 diabetes. Patients will be randomised to one of 6 treatm...
Bone Turnover in Type 2 Diabetes Patients
Background: Incretin hormones are hormones produced by the gut in response to food intake. These hormones help the body to control the metabolism of glucose (sugar). In particular, two...
Incretin hormones are hormones produced by the gut in response to food intake. These hormones help the body to control the metabolism of glucose (sugar). In particular, two incretin hormon...
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
We hypothesize that the hearts of HIV+ people with The Metabolic Syndrome use and oxidize fats and sugars inappropriately, and that this may impair the heart's ability to pump blood. We h...
Type 2 diabetes mellitus is a metabolic disorder that is primarily characterized by insulin resistance, relative insulin deficiency, and hyperglycemia. People with type 2 diabetes are at h...
This 2 arm study will compare the effects of aleglitazar and Actos, added to preexisting oral antihyperglycemic therapy and/or diet and exercise, on renal function in patients with type 2...
The aim of this study is to investigate the efficacy and safety of an insulin-sensitizer (Actos) added to a standard Pegasys/Copegus combination therapy of chronic hepatitis C in patients...
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
The purpose of this study is to evaluate the combination of alogliptin, once daily (QD), and pioglitazone in subjects with type 2 diabetes mellitus who are inadequately controlled with die...
PubMed Articles
OBJECTIVES: To evaluate the safety of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in nondiabetic patients with Alzheimer disease (AD) and to explore treatment effect size...
Videos
CanalN: Arbizu sobre investigación a Alejandro Toledo: hay indicios de actos de corrupción
Canal N www.americanoticias.pe.
